FREE Case Review (866) 588-0600

Invokana Lawsuit Filed in Alabama

An Alabama woman who allegedly developed diabetic ketoacidosis after taking Invokana has filed a lawsuit against Janssen Pharmaceuticals.

An Alabama woman who allegedly developed diabetic ketoacidosis (DKA) after taking Invokana (generic: canagliflozin) has filed a product liability lawsuit against Janssen Pharmaceuticals.

Free Confidential Lawsuit Evaluation: If you someone you know was injured by Invokana side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the problem?

February 11, 2016 – According to allegations raised in the complaint, plaintiff began taking Invokana in December 2014, and shortly thereafter developed diabetic ketoacidosis. Plaintiff claims she was unaware of the risk of DKA from Invokana, and accuses Janssen of negligence for failure to adequately warn or properly study the drug. She also claims the company was negligent for marketing Invokana ‘off-label’ to treat type 1 diabetes and lower blood pressure. The complaint was filed in the Southern District of Alabama under case number 1:15-cv-00636.

Ketoacidosis is a dangerous, potentially fatal medical condition that occurs when there isn’t enough insulin in the body. FDA has warned diabetes patients who use SGLT2 inhibitor drugs like Invokana to be aware of the symptoms of ketoacidosis, which include thirst, frequent urination, nausea, abdominal pain, weakness, fruity-scented breath and confusion.

The Alabama lawsuit is similar to another complaint (case #15-12-00653) recently filed in the Philadelphia Court of Common Pleas by a man who claims he was diagnosed with diabetic ketoacidosis just 3 months after beginning treatment with Invokana. The suits follow a recent FDA warning which specifically discussed the ketoacidosis risk associated with SGLT-inhibitors, and required manufacturers to update their products’ labeling with information about DKA.

In addition to Invokana, other SGLT-2 inhibitors that may increase the risk of ketosis include:

Do I Have an Invokana Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.

Free Confidential Case Evaluation: Again, if you were injured by Invokana, you should contact our law firm immediately. You may be entitled to a settlement by filing a class action suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition